Search

Phuoc Tran

Examiner (ID: 2223, Phone: (571)272-7399 , Office: P/2668 )

Most Active Art Unit
2668
Art Unit(s)
2721, 2668, 2714, 2621, 2624, 2616, 2606
Total Applications
2031
Issued Applications
1724
Pending Applications
115
Abandoned Applications
213

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20414120 [patent_doc_number] => 12497390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same [patent_app_type] => utility [patent_app_number] => 17/799054 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1896 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 287 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799054 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/799054
Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same Feb 25, 2021 Issued
Array ( [id] => 18146304 [patent_doc_number] => 20230020161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => Tricyclic Modulators of PP2A [patent_app_type] => utility [patent_app_number] => 17/907949 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907949 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907949
Tricyclic Modulators of PP2A Feb 25, 2021 Abandoned
Array ( [id] => 20129111 [patent_doc_number] => 12371413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Method for preparing 2-iodoheterocyclic aryl ether at room temperature [patent_app_type] => utility [patent_app_number] => 18/012586 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 0 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012586 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/012586
Method for preparing 2-iodoheterocyclic aryl ether at room temperature Feb 21, 2021 Issued
Array ( [id] => 18739479 [patent_doc_number] => 20230348409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => METAL CATALYST AND HYDROGEN GAS FREE APPROACHES FOR SELECTIVE REDUCTION OF ALDEHYDE TO METHYL GROUP OF DIFFERENT SUBSTITUTED FURANS [patent_app_type] => utility [patent_app_number] => 17/800701 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800701
METAL CATALYST AND HYDROGEN GAS FREE APPROACHES FOR SELECTIVE REDUCTION OF ALDEHYDE TO METHYL GROUP OF DIFFERENT SUBSTITUTED FURANS Feb 18, 2021 Pending
Array ( [id] => 18360683 [patent_doc_number] => 20230142274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => SUBSTITUTED ARYL COMPOUND [patent_app_type] => utility [patent_app_number] => 17/800853 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800853 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800853
SUBSTITUTED ARYL COMPOUND Feb 18, 2021 Abandoned
Array ( [id] => 17822639 [patent_doc_number] => 11427576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => Indole compounds and their use [patent_app_type] => utility [patent_app_number] => 17/179286 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 67 [patent_no_of_words] => 55960 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179286 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179286
Indole compounds and their use Feb 17, 2021 Issued
Array ( [id] => 16900608 [patent_doc_number] => 20210179524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => ANTIMALARIAL COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/177314 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39661 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/177314
Antimalarial compositions and uses thereof Feb 16, 2021 Issued
Array ( [id] => 17082014 [patent_doc_number] => 20210277020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/174000 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174000 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/174000
HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS Feb 10, 2021 Abandoned
Array ( [id] => 17036607 [patent_doc_number] => 20210253565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => MONOACYLGLYCEROL LIPASE MODULATORS [patent_app_type] => utility [patent_app_number] => 17/171559 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171559 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/171559
Monoacylglycerol lipase modulators Feb 8, 2021 Issued
Array ( [id] => 18328164 [patent_doc_number] => 11633377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Treatment of circadian rhythm disorders [patent_app_type] => utility [patent_app_number] => 17/169928 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 19217 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169928 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169928
Treatment of circadian rhythm disorders Feb 7, 2021 Issued
Array ( [id] => 17314419 [patent_doc_number] => 20210403467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 17/167507 [patent_app_country] => US [patent_app_date] => 2021-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17167507 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/167507
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Feb 3, 2021 Abandoned
Array ( [id] => 18216391 [patent_doc_number] => 11591313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/168109 [patent_app_country] => US [patent_app_date] => 2021-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 43935 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168109 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/168109
Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof Feb 3, 2021 Issued
Array ( [id] => 18202330 [patent_doc_number] => 11584712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Alkylamine-substituted perthiocarbamates as dual precursors to hydropersulfide and carbonyl sulfide [patent_app_type] => utility [patent_app_number] => 17/166434 [patent_app_country] => US [patent_app_date] => 2021-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 32 [patent_no_of_words] => 28907 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/166434
Alkylamine-substituted perthiocarbamates as dual precursors to hydropersulfide and carbonyl sulfide Feb 2, 2021 Issued
Array ( [id] => 16854844 [patent_doc_number] => 20210155589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE [patent_app_type] => utility [patent_app_number] => 17/164825 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164825 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/164825
Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide Jan 31, 2021 Issued
Array ( [id] => 18844430 [patent_doc_number] => 20230406834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/252300 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252300 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/252300
PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS Jan 20, 2021 Pending
Array ( [id] => 16839421 [patent_doc_number] => 20210147433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING [patent_app_type] => utility [patent_app_number] => 17/153727 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/153727
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making Jan 19, 2021 Issued
Array ( [id] => 19491597 [patent_doc_number] => 12110293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Substituted triazolo quinoxaline derivatives [patent_app_type] => utility [patent_app_number] => 17/152930 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53873 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 679 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152930 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/152930
Substituted triazolo quinoxaline derivatives Jan 19, 2021 Issued
Array ( [id] => 18802301 [patent_doc_number] => 11835457 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Fluorescent composition for detecting biological material [patent_app_type] => utility [patent_app_number] => 17/151680 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4756 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151680 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/151680
Fluorescent composition for detecting biological material Jan 18, 2021 Issued
Array ( [id] => 17905454 [patent_doc_number] => 11459297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt [patent_app_type] => utility [patent_app_number] => 17/151901 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7722 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151901 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/151901
Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt Jan 18, 2021 Issued
Array ( [id] => 16961500 [patent_doc_number] => 20210212999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 17/151577 [patent_app_country] => US [patent_app_date] => 2021-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151577 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/151577
Use of riluzole prodrugs to treat Alzheimer's disease Jan 17, 2021 Issued
Menu